Press Release Archive
-
Janssen Discontinues Development of Flubendazole Formulation to Treat OnchocerciasisResearch supported Johnson & Johnson’s commitment to the 2012 London Declaration on Neglected Tropical Diseases and yielded important findings
-
EPREX® (epoetin alfa) Marketing Authorisation Extended to Include Treatment of Symptomatic Anaemia in Patients with Low or Intermediate-1-Risk Myelodysplastic SyndromesFrench Health Authority ANSM grants approval in the Mutual Recognition Procedure; the relevant health authorities are required to implement the new indication within 30 days
-
Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases
-
New Phase 3 Study Finds XARELTO® to Be Superior to Aspirin for Long-Term Prevention of Recurrent Blood Clots Without Observing any Significant Increase in Major Bleeding in Patients with Venous Thromboembolism
-
Mitek Sports Medicine Introduces Comprehensive Knee Arthroscopy Platform for ACL and Meniscal RepairNew Offering Combines Performance with Reproducibility and Operating Room Efficiency
-
DePuy Synthes Companies Announces New ATTUNE® Revision Fixed Bearing Tibial Base and Cemented Stem for Primary and Revision Surgeries
-
Johnson & Johnson Reports that Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study
-
New Report Demonstrates The Clinical And Economic Value Of The Attune® Knee System In Today’s Value-Based EnvironmentSurvivorship, Economic and Patient Reported Data Are Needed to Measure Outcomes and Cost Benefits
-
Johnson & Johnson Names Winners of First Africa Innovation ChallengeCompetition Part of Company’s Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent
-
Ethicon and Depuy Synthes Introduce Customized Wound Closure Kits Aiming to Improve Efficiencies and Patient Outcomes in Orthopaedic SurgerySTRATAFIX™ and DERMABOND® advanced wound closure products are available in one convenient kit through DePuy Synthes